WO2000008157A3 - Genes humains transporteurs d'anions atnov - Google Patents

Genes humains transporteurs d'anions atnov Download PDF

Info

Publication number
WO2000008157A3
WO2000008157A3 PCT/US1999/017823 US9917823W WO0008157A3 WO 2000008157 A3 WO2000008157 A3 WO 2000008157A3 US 9917823 W US9917823 W US 9917823W WO 0008157 A3 WO0008157 A3 WO 0008157A3
Authority
WO
WIPO (PCT)
Prior art keywords
atnov
anion transporter
transporter genes
expression
genes
Prior art date
Application number
PCT/US1999/017823
Other languages
English (en)
Other versions
WO2000008157A2 (fr
Inventor
Boris Laubert
Gizela Cardoso
Ping Hu
Andrew P Miller
Alan J Buckler
Original Assignee
Axys Pharm Inc
Boris Laubert
Gizela Cardoso
Ping Hu
Andrew P Miller
Alan J Buckler
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Axys Pharm Inc, Boris Laubert, Gizela Cardoso, Ping Hu, Andrew P Miller, Alan J Buckler filed Critical Axys Pharm Inc
Priority to AU53406/99A priority Critical patent/AU5340699A/en
Priority to EP99939045A priority patent/EP1141282A2/fr
Publication of WO2000008157A2 publication Critical patent/WO2000008157A2/fr
Publication of WO2000008157A3 publication Critical patent/WO2000008157A3/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00Genetically modified animals
    • A01K2217/05Animals comprising random inserted nucleic acids (transgenic)
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00Genetically modified animals
    • A01K2217/07Animals genetically altered by homologous recombination
    • A01K2217/075Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

L'invention concerne des méthodes permettant d'isoler des gènes Atnov. Les compositions d'acide nucléique Atnov permettent d'identifier des protéines homologues ou associées ainsi que les séquences d'ADN codant pour ces protéines, de produire des compositions qui modulent l'expression ou la fonction de la protéine, et d'étudier les mécanismes physiologiques associés. En outre, la modulation de l'activité génique in vivo est utilisée à des fins prophylactiques et thérapeutiques, telles que l'identification du type cellulaire sur la base de l'expression et analogues.
PCT/US1999/017823 1998-08-07 1999-08-06 Genes humains transporteurs d'anions atnov WO2000008157A2 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
AU53406/99A AU5340699A (en) 1998-08-07 1999-08-06 Human anion transporter genes atnov
EP99939045A EP1141282A2 (fr) 1998-08-07 1999-08-06 Genes humains transporteurs d'anions atnov

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9583598P 1998-08-07 1998-08-07
US60/095,835 1998-08-07

Publications (2)

Publication Number Publication Date
WO2000008157A2 WO2000008157A2 (fr) 2000-02-17
WO2000008157A3 true WO2000008157A3 (fr) 2000-11-23

Family

ID=22253806

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1999/017823 WO2000008157A2 (fr) 1998-08-07 1999-08-06 Genes humains transporteurs d'anions atnov

Country Status (3)

Country Link
EP (1) EP1141282A2 (fr)
AU (1) AU5340699A (fr)
WO (1) WO2000008157A2 (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4953300A (en) * 1999-06-03 2000-12-28 Sankyo Company Limited Novel transporter gene expressed in liver
EP2316848A1 (fr) * 1999-09-21 2011-05-04 Chugai Seiyaku Kabushiki Kaisha Gènes transporteurs OATP-B, C, D et E
EP1272521A2 (fr) * 2000-03-27 2003-01-08 Bayer Aktiengesellschaft Regulation de la proteine humaine apparentee a oatp2
CN1324855A (zh) * 2000-05-24 2001-12-05 上海博德基因开发有限公司 一种新的多肽——人组织阴离子转运多肽10和编码这种多肽的多核苷酸
GB0013105D0 (en) * 2000-05-30 2000-07-19 Univ Bristol Therapeutic compounds
US20020090622A1 (en) * 2000-08-23 2002-07-11 Monisola Adeokun Chemical compounds
US7807447B1 (en) 2000-08-25 2010-10-05 Merck Sharp & Dohme Corp. Compositions and methods for exon profiling
EP1412387A2 (fr) * 2000-10-27 2004-04-28 Incyte Genomics, Inc. Transporteurs et circuit ioniques
GB0213579D0 (en) * 2002-06-13 2002-07-24 Astrazeneca Ab Methods
GB0317592D0 (en) 2003-07-26 2003-08-27 Astrazeneca Ab Method
DE102008011008B4 (de) 2008-02-25 2013-05-29 Otto R. Hofmann Vorrichtung und Verfahren zur Beeinflussung von elektrisch leitfähigen Fluiden mit Hilfe der Lorentzkraft

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997031111A2 (fr) * 1996-02-22 1997-08-28 Introgene B.V. Famille de transporteurs d'anions organiques, acides nucleiques codant ceux-ci, cellules les comprenant et procedes d'utilisation associes

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997031111A2 (fr) * 1996-02-22 1997-08-28 Introgene B.V. Famille de transporteurs d'anions organiques, acides nucleiques codant ceux-ci, cellules les comprenant et procedes d'utilisation associes

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
ABE T., ET AL.: "Identification of a Novel Gene Family Encoding Human Liver-specific Organic Anion Transporter LST-1", J. BIOL. CHEM., vol. 274, no. 24, 11 June 1999 (1999-06-11), pages 17159 - 17163, XP000877288 *
Embase accession number AB026257.1 Created 08-JUN-1999 , Sequence characterization: Homo sapiens mRNA for organic anion transporter OATP-C, complete *
HSIANG B.H., ZHU Y., WANG Z., WU Y., SASSEVILLE V., YANG W.-P.,: "A novel human hepatic organic anion transporting polypeptide (OATP2) Identification of a liver-specific human organic anion transporting polypeptide and identification of rat and human hydroxymethylglutaryl-coa reductase inhibitor transporter.", JOURNAL OF BIOLOGICAL CHEMISTRY (MICROFILMS), vol. 274, no. 52, 24 December 1999 (1999-12-24), MD US, pages 37161 - 37168, XP002131865 *
KULLAK-UBLICK ET AL: "Molecular and functional characterization of an organic anion transporting polypeptide cloned from human liver", GASTROENTEROLOGY, vol. 109, 1 October 1995 (1995-10-01), pages 1274 - 1282, XP002092892, ISSN: 0016-5085 *

Also Published As

Publication number Publication date
EP1141282A2 (fr) 2001-10-10
AU5340699A (en) 2000-02-28
WO2000008157A2 (fr) 2000-02-17

Similar Documents

Publication Publication Date Title
WO2000027994A3 (fr) Sequence genomique de chlamydia pneumoniae
WO2002014358A3 (fr) Nouvelles proteines secretees et leurs utilisations
HUP0004611A2 (hu) APRIL, egy új növekedési hatású fehérje
EP0796913A3 (fr) Protéine stimulant la dissociation du GDP, protéine d'assemblage de nucléosome spécifique au cerveau, enzyme de conjugaison d'ubiquitine spécifique aux muscles du squelette, protéine de prolifération de cellule, phosphatidylinositolkinase, protéines apparentés à nel
WO1999031236A3 (fr) ADNc PROLONGES POUR PROTEINES SECRETEES
CY1105398T1 (el) 5΄ ESTs ΓΙΑ ΕΚΚΡΙΤΙΚΕΣ ΠΡΩΤΕΪΝΕΣ ΠΟΥ ΕΚΦΡΑΖΟΝΤΑΙ ΣΕ ΔΙΑΦΟΡΟΥΣ ΙΣΤΟΥΣ
WO1998031800A3 (fr) Proteines humaines
WO2002029086A3 (fr) Sequences d'acide nucleique differentiellement exprimees dans un tissu cancereux
WO2001029222A3 (fr) Polypeptides ayant une activite phospholipase b et acides nucleiques codant ces derniers
WO1999054461A3 (fr) Sequences d'acide nucleique humaines provenant d'une tumeur de l'endometre
EP0804609A4 (fr) NOUVEAUX GENES DE REPONSE p53
WO2002008277A3 (fr) Acides nucleiques, vecteurs, cellules hotes, polypeptides et leurs utilisations
AU2740100A (en) A novel, prostate-specific gene for diagnosis, prognosis and management of prostate cancer
CA2281895A1 (fr) Ikb kinases
WO2000008157A3 (fr) Genes humains transporteurs d'anions atnov
AU7489098A (en) Polypeptides having aminopeptidase activity and nucleic acids encoding same
AUPP472398A0 (en) Protease susceptibility II
CA2294566A1 (fr) Proteines ikk-.alpha., acides nucleiques et procedes
WO2000052136A3 (fr) Enzymes de glycosylation humaines
WO2000009693A3 (fr) Identification du gene responsable du phenotype de la souris 'scurfy' et de son orthologue humain
ATE310085T1 (de) Cyclin-e2 proteine und dafür kodierende gene
WO1998011234A3 (fr) Proteines kinases humaines
WO1999002704A3 (fr) Phosphatase a double specificite et procedes d'utilisation
WO2003031572A3 (fr) Polypeptides therapeutiques, acides nucleiques codant ces derniers et methodes d'utilisation
WO1999054447A3 (fr) Sequences d'acide nucleique provenant de tissus tumoraux de la vessie

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWE Wipo information: entry into national phase

Ref document number: 1999939045

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1999939045

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 1999939045

Country of ref document: EP